ANTIPODES PARTNERS Ltd

Source: SEC Form 13F · as of Mar 2026

ANTIPODES PARTNERS Ltd holds 30 biotech & pharma companies tracked by BioSniper, totaling $362.7M in value as of Mar 2026 (SEC Form 13F).

Companies held

Total value held

$362.7M

Company	Shares	Value
MRKMerck & Co., Inc.	1,441,266	$173.4M
GMEDGlobus Medical Inc.	897,607	$77.3M
ALNYALNYLAM PHARMACEUTICALS, INC.	145,310	$48.1M
DGXQuest Diagnostics Incorporated	162,589	$31.9M
JNJJOHNSON & JOHNSON	101,023	$24.7M
HUMAHumacyte Inc.	5,723,750	$3.5M
GPCRStructure Therapeutics Inc.	45,361	$2.2M
SDGRSchrodinger, Inc.	56,989	$647K
IMNMImmunome Inc.	7,818	$171K
CORCencora Inc.	333	$105K
QGENQIAGEN N.V.	1,989	$80K
GILDGILEAD SCIENCES, INC.	557	$78K
REGNREGENERON PHARMACEUTICALS, INC.	97	$75K
TEVATeva Pharmaceutical Industries Limited	2,234	$67K
VRTXVERTEX PHARMACEUTICALS INC / MA	127	$57K
TARSTarsus Pharmaceuticals, Inc.	555	$39K
ARGXARGENX SE	50	$37K
TNGXTango Therapeutics, Inc.	1,622	$34K
IDYAIDEAYA Biosciences, Inc.	917	$31K
DNTHDianthus Therapeutics, Inc. /DE/	364	$31K
IRONDisc Medicine, Inc.	476	$30K
NUVLNuvalent, Inc.	275	$28K
ATAIAtai Beckley N.V.	7,529	$27K
TERNTerns Pharmaceuticals, Inc.	455	$24K
RLMDRELMADA THERAPEUTICS, INC.	3,035	$21K
VRDNViridian Therapeutics, Inc.\DE	834	$16K
ORICOric Pharmaceuticals, Inc.	1,278	$16K
BIOABioAge Labs, Inc.	915	$16K
CABACabaletta Bio, Inc.	5,616	$15K
ANLAdlai Nortye Ltd.	2,051	$14K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.